After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold. The ...
Tandem Diabetes Care announced today that it received approval to deliver Lyumjev ultra-rapid acting insulin with its t:slim ...
First-of-its-kind research aboard Axiom Mission 4 shows diabetes monitoring tools can function reliably in space, signaling ...
“With chronic stress, cortisol stays high and disrupts multiple systems. It drives cravings for sugary and fatty foods, ...
An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, ...
RedChip Companies will air interviews with BioVie Inc. (NASDAQ:BIVI) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip ...
CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...
This month most of the startups that caught our attention include a one making a more environmentally friendly fertilizer, a ...
Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the ...
Glucose, nutrients, and oxygen are crucial for normal brain function. Providing the brain with fuel via diet and exercise is ...
A variety of laboratory tests are available to determine whether a patient has good sleep health, but a simple way to ...
Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback